CD274 and non-small cell lung carcinoma: irAEs were positively correlated with anti-PD-1/PD-L1 inhibitor efficacy in patients with NSCLC and patients with melanoma [32–36], but there has been some speculation that this correlation is not robust [37, 38]; a negative correlation has been suggested in patients with small-cell lung cancer [39].